Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination
核心 B:对疫苗接种的先天和适应性反应的系统生物学分析
基本信息
- 批准号:10201499
- 负责人:
- 金额:$ 512.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-13 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVATAC-seqAddressAspirate substanceAwardBloodCOVID-19Cell Culture TechniquesCellsCloningCompetenceDiagnosticDiseaseDonor personEpigenetic ProcessEpithelial CellsEpitopesGenetic TranscriptionGrantHeterogeneityHospitalsHumanImmuneImmune responseImmune systemImmunityImmunologyInfectionInnate Immune ResponseKnowledgeLearningLungLung TransplantationMetabolicMolecularMolecular ProfilingMyelogenousMyeloid CellsNatural ImmunityParentsPathogenesisPathogenicityPeripheral Blood Mononuclear CellSamplingScienceSiteStimulusStructure of parenchyma of lungSystemSystems BiologyTherapeuticVaccinationVaccine DesignVaccinesVirusWorkairway epitheliumbiological systemscoronavirus diseasedesignepigenomicsglobal healthimprintindexinginsightmacrophagemetabolomicsmonocytemultiple omicsnovelpandemic diseasepreventprogramsresponsesingle-cell RNA sequencingtranscriptometranscriptomicstransplant centers
项目摘要
The recent emergence of the novel, pathogenic SARS-coronavirus 2 (SARS-CoV-2) pandemic
poses a major global health challenge. Coronavirus disease (COVID-19) is caused by SARS-
CoV-2 and represents the causative agent of a potentially fatal disease. Science has moved very
rapidly in isolating, sequencing, and cloning the virus, and developing diagnostic kits, within a
matter of weeks. However, major knowledge gaps remain about the dynamic interaction between
the human immune system and the SARS-CoV-2. In particular, several fundamental questions
regarding its pathogenesis, and the mechanisms of protective immunity that need to be induced
by vaccination, remain unanswered. Learning how the immune system senses SARS-CoV-2
infection and orchestrates protective immunity is critical for designing effective vaccines and
therapeutics. Our previous work using systems biology, multi-omics approaches to analyze
immune responses to vaccination in humans has delineated molecular signatures of innate
immunity to vaccination and infection and have provided rich mechanistic insights into the immune
response. In this proposal, we propose a site-specific study to analyze samples from the
IMPACC sub-study performed at Emory. We will use an integrated multi-omics approach (single
cell transcriptomics, metabolomics, single cell epigenomics) to study innate immunity to COVID-
19 infection in humans. We will obtain PBMCs and tracheal aspirate samples from the IMPACC
sub-study that will be conducted at Emory. We will address the following questions: What are the
molecular and cellular signatures of the immune response to COVID-19 infection in the blood and
tracheal aspirates of infected subjects? Does COVID-19 infection exert an epigenetic imprint of
innate immunity? What is the molecular landscape and function of myeloid cell subsets and airway
epithelial cells in the healthy lung, and following COVID-19 infection? These questions will be
addressed in the following specific aims: 1) Determine the single cell transcriptional and
epigenetic landscape of the immune response to COVID-19 infection in blood and tracheal
aspirates, and 2) Determine the molecular identity and functions of myeloid cell subsets and
epithelial cells in human lung and their response to COVID-19 infection. These studies will provide
significant insight into the human immune response to COVID-19 infection that can be leveraged
for designing vaccines and therapeutics to prevent or treat the infection.
最近出现的新型致病性sars -冠状病毒2 (SARS-CoV-2)大流行
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark Joseph Mulligan其他文献
Mark Joseph Mulligan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark Joseph Mulligan', 18)}}的其他基金
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) - DMID 21-0012
纽约大学疫苗和治疗评估单位 (NYU VTEU) 的成立 - DMID 21-0012
- 批准号:
10411291 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU) – DMID 21-0004
纽约大学疫苗和治疗评估单位 (NYU VTEU) 成立 — DMID 21-0004
- 批准号:
10416210 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10493613 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10493604 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Core B: System Biological Analyses of Innate and Adpative Responses to Vaccination
核心 B:对疫苗接种的先天和适应性反应的系统生物学分析
- 批准号:
10345983 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10265637 - 财政年份:2021
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10228783 - 财政年份:2020
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10534123 - 财政年份:2020
- 资助金额:
$ 512.52万 - 项目类别:
Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)
纽约大学疫苗和治疗评估中心(NYU VTEU)成立
- 批准号:
10306410 - 财政年份:2020
- 资助金额:
$ 512.52万 - 项目类别:
Vaccine and Treatment Evaluation Units: Overall Administration, Clinical Operations Support, Protocol Development, Implementation and Assays.
疫苗和治疗评估单位:总体管理、临床操作支持、方案制定、实施和测定。
- 批准号:
10083147 - 财政年份:2019
- 资助金额:
$ 512.52万 - 项目类别:
相似国自然基金
基于ATAC-seq与DNA甲基化测序探究染色质可及性对莲两生态型地下茎适应性分化的作用机制
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
利用ATAC-seq联合RNA-seq分析TOP2A介导的HCC肿瘤细胞迁移侵
袭的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
靶向治疗动态调控肺癌细胞DNA可接近性的ATAC-seq分析
- 批准号:81802809
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
运用ATAC-seq技术分析染色质可接近性对犏牛初级精母细胞基因表达的调控作用
- 批准号:31802046
- 批准年份:2018
- 资助金额:27.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq和RNA-seq研究CWIN调控采后番茄果实耐冷性作用机制
- 批准号:31801915
- 批准年份:2018
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
基于ATAC-seq高精度预测染色质相互作用的新方法和基于增强现实的3D基因组数据可视化
- 批准号:31871331
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Project #2 Integrated single-nucleus multi-omics (ATAC-seq+RNA-seq or chromatin accessibility + RNA-seq) of human TGs
项目
- 批准号:
10806548 - 财政年份:2023
- 资助金额:
$ 512.52万 - 项目类别:
A transposase system for integrative ChIP-exo and ATAC-seq analysis at single-cell resolution
用于单细胞分辨率综合 ChIP-exo 和 ATAC-seq 分析的转座酶系统
- 批准号:
10210424 - 财政年份:2018
- 资助金额:
$ 512.52万 - 项目类别:
EAPSI: Developing Single Nucleus ATAC-seq to Map the Ageing Epigenome
EAPSI:开发单核 ATAC-seq 来绘制衰老表观基因组图谱
- 批准号:
1714070 - 财政年份:2017
- 资助金额:
$ 512.52万 - 项目类别:
Fellowship Award
A cloud-based learning module to analyze ATAC-seq and single cell ATAC-seq data
基于云的学习模块,用于分析 ATAC-seq 和单细胞 ATAC-seq 数据
- 批准号:
10558379 - 财政年份:2001
- 资助金额:
$ 512.52万 - 项目类别:














{{item.name}}会员




